Vantage logo

Freenome aims to take on the big beasts

Forthcoming data in colorectal cancer screening could put the company’s liquid biopsy on the market – but it looks like Guardant might get there first.

Vantage logo

Device makers buy big

Whether sitting on a pile of cash or guarding against growing pressures, acquisitions are the answer.